Skip to main content

NEXGEL, INC.

corporate_fare Company Profile

NEXGEL, INC.

NXGL·NASDAQ·Industrial Applications And Services·CIK 0001468929

Our Company, incorporated in Delaware on January 13, 2009, manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels. These gels are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels, leveraging proprietary manufacturing technologies. It operates as a contract manufacturer, supplying its gels to third parties who integrate them into their own products. Additionally, Our Company offers a line of branded consumer products sold directly to consumers, alongside custom and white label opportunities that combine its gels with proprietary branded products. All gel products are manufactured using proprietary and non-proprietary mixing, coating, and cross-linking technologies. These technologies allow for the production of gels meeting rigid tolerance specifications across various physical characteristics, including thickness, water content, adherence, absorption, moisture vapor transmission rate, and release rate, while maintaining product integrity. The company also offers broad choices in liners for gel coating, enabling the determination of tolerances in moisture vapor transmission rate and active ingredient release rates, and personalization of color and texture. In May 2023, Our Company formed CG Converting and Packaging, LLC, a joint venture with CG Laboratories, Inc. located in Granbury, Texas, in which it holds a 50% interest. This joint venture expands its capacity to deliver finished goods to its customer base. As a contract manufacturer, Our Company's hydrogels are currently marketed in the U.S. and abroad by its customers for applications such as Drug Delivery.

NEXGEL, INC. (NASDAQ:NXGL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors NXGL SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Transformative Acquisition Expected to Triple NEXGEL Revenue, Drive Immediate Profitability
  • NEXGEL Secures Up to $56.7M in Highly Dilutive Convertible Note Facility, Requires Shareholder Approval for Reverse Split and 10x Share Increase
  • NEXGEL Secures Up to $1.8M in Highly Dilutive Senior Secured Convertible Notes, with Potential for Additional $14.9M
  • NEXGEL Appoints Former CFO Adam Drapczuk III as Interim Chief Financial Officer

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$11.42M
Net Income
-$3M
Diluted EPS
-$0.38
Op. Cash Flow
-$1.31M
Free Cash Flow
-$1.38M
Gross Profit
$4.51M
Operating Income
-$3.35M
Cash & Equivalents
$317K
Debt / Equity
0.00×
Net Margin
-26.3%
Shares Outstanding
8.14M sh
Source: 10-K · filed 2026-04-30 · accession 0001493152-26-020692
$0.5956 +0.01% today
52-week range · as of 2026-06-09 $0.4811 – $2.89
Market cap
$6.97M
Volume
584.5K (4.5× avg)
3-mo avg 130.4K
Live data · 2026-06-12 11:04 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed NXGL - Filings & News (Page 2)

NXGL
Mar 10, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.40
Real-time Price: $0.5956 info
Change: -$0.7994 (-57%) info
Market Cap: $6.968M info
NXGL
Feb 11, 2026, 8:33 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $0.5956 info
Change: -$0.7244 (-55%) info
Market Cap: $6.968M info
NXGL
Feb 10, 2026, 4:13 PM EST
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.32
Real-time Price: $0.5956 info
Change: -$0.7244 (-55%) info
Market Cap: $6.968M info
NXGL
Jan 07, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $0.5956 info
Change: -$1.12 (-65%) info
Market Cap: $6.968M info